The advancement of imaging in diagnosis of prostate cancer

Michał Osuchowski
ID
Email src
David Aebisher
ID
Email src
Joanna Gustalik
ID
Email src
Dorota Bartusik-Aebisher
ID
Email src
Ewa Kaznowska
ID
Department of Morphological Sciences, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland
Department of Photomedicine and Physical Chemistry, Medical College of Rzeszów University, Rzeszów, Poland
Department of Pathomorphology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland
Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszow, University of Rzeszow, Rzeszow, Poland
Department of Pathology of University Clinical Hospital in Rzeszów, Rzeszów, Poland
Received: 15 November 2018 / Accepted: 15 January 2019 / Published: 30 March 2019

Abstract

Introduction. Multiple imaging methods have been used to stage prostate carcinoma. Some of them are easily accessible, others very accurate. The advancements over many years have been taken under consideration and now every imaging method has a specific role in the diagnosis of this malignancy.

Aim. There are over 1,100,000 cases of prostate carcinoma diagnosed every year around the world. Imaging examinations have to be introduced to accurately stage, and therefore properly treat this disease. This review concentrates on advantages and disadvantages of different imaging methods.

Material and methods. The literature search was performed.

Results. Imaging methods serve specific goals. TRUS is recommended for acquiring biopsy specimen due to high accessibility and low cost of the examination.

Conclusion. The best tool for staging prostate carcinoma and finding suspicious lesions when attempting second biopsy is mpMRI or bpMRI. 

 

Cite

Osuchowski M, Aebisher D, Gustalik J, Bartusik-Aebisher D, Kaznowska E. The advancement of imaging in diagnosis of prostate cancer. Eur J Clin Exp Med. 2019;17(1):67–70. doi: 10.15584/ejcem.2019.1.11

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited